Dabigatranate capsules are usually taken with or after meals. It is swallowed with water, as directed by your doctor, depending on your own condition. Dabigatran etexilate capsules are a new anticoagulant drug used for the prevention of stroke and embolism in adult patients with non-valvular atrial fibrillation who have risk factors for prior stroke, transient ischemic attack, or embolism in the body, for the treatment of acute deep vein thrombosis or pulmonary embolism, and for the prevention of related deaths. The most common side effect of dabigatran etexilate is bleeding, especially from the mucous membranes of the skin. Other adverse reactions include bloating, abdominal pain, dyspepsia, nausea, vomiting, urticaria, and rash. It is contraindicated in people who are allergic to the product and its components, in patients with severe renal impairment, in patients with significant active bleeding, and in patients with artificial heart valves requiring anticoagulant therapy. It should be used with caution in pregnant and lactating women. However, there are some benefits of dabigatranate capsules, compared to the risk of bleeding on warfarin is relatively low, and does not require regular checkups to monitor coagulation, relatively speaking, it is still relatively safe. The drug should be used under medical supervision.